Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-t inhibitors

MA40060AUndetermined Publication Date: 2016-01-07TAKEDA PHARMA CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA40060
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-12-25
Filing Date: 2015-06-30
Publication Date: 2016-01-07

Application Information

Patent Timeline

25 Dec 2014

Priority

30 Jun 2015

Application

MA40060

07 Jan 2016

Publication

MA40060A

IPC: A61K31/4375; A61K31/472; A61K31/4741; A61P11/06; A61P17/06; A61P19/02; A61P43/00; C07D217/14; C07D471/04; C07D491/14

CPC: C07D217/14; C07D491/14; C07D217/26; C07D471/04; C07D491/048; C07D491/056; A61P1/00; A61P1/04

Inventors: TOMATA Yoshihide; YAMAMOTO Satoshi

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Provided are heterocyclic compounds having a rorγt inhibitory action represented by the formula (i): wherein each symbol is as defined in the specification, or a salt thereof.

Need to check novelty before this filing date? Find Prior Art